Home/Filings/4/0001447348-09-000020
4//SEC Filing

PROGENICS PHARMACEUTICALS INC 4

Accession 0001447348-09-000020

CIK 0000835887operating

Filed

Oct 18, 8:00 PM ET

Accepted

Oct 19, 10:58 AM ET

Size

8.6 KB

Accession

0001447348-09-000020

Insider Transaction Report

Form 4
Period: 2009-10-16
MADDON PAUL J
Chief Executive Officer/CSO10% Owner
Transactions
  • Purchase

    Common Stock

    2009-10-16$4.88/sh+18,500$90,243804,942 total
Footnotes (1)
  • [F1]This transaction was executed in multiple trades at prices ranging from $4.839 to $4.930. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Issuer

PROGENICS PHARMACEUTICALS INC

CIK 0000835887

Entity typeoperating
IncorporatedDE

Related Parties

1
  • filerCIK 0000835887

Filing Metadata

Form type
4
Filed
Oct 18, 8:00 PM ET
Accepted
Oct 19, 10:58 AM ET
Size
8.6 KB